Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supportive Psychotherapy As An Adjunct To Risperidone in Schizophrenia
NCT07477301Phase 2Completed
- Sponsor
- Hasanuddin University
- Start
- Dec 2024
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia (2 arms), sponsored by Hasanuddin University. Primary endpoints: Montreal Cognitive Assessment - Indonesian version at 6 weeks and high-sensitivity C-reactive protein at 6 weeks. Started Dec 2024; status: completed.
02
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT07477301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07477301.